GO:0042092 type 2 immune response: Initiation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042092 (type 2 immune response) is the biological process that defends against extracellular organisms such as helminths and underlies allergic pathology, orchestrated mainly by IL-4, IL-5, IL-10 and IL-13.
• The response is initiated by sentinel cells, including epithelial tuft cells, that sense helminth-derived and allergen-derived cues and release alarmins such as IL-25, IL-33 and TSLP.
• Group 2 innate lymphoid cells (ILC2s), Th2 cells, eosinophils, basophils, mast cells and nuocytes are the principal cellular effectors of the response.
• Type 2 immunity drives class switching toward IgE and IgG1, mucus production, smooth-muscle contraction and tissue repair programs.
• Metabolic and tissue-repair programs, including ILC2-mediated regeneration, are tightly coupled to type 2 cytokine signaling.
• CRISPR knockout, knock-in, point-mutation and overexpression models allow causal testing of type 2 immune response genes in primary cells and reporter lines.
Description
The type 2 immune response (GO:0042092) is a specialized branch of adaptive and innate immunity that evolved to control extracellular pathogens, particularly helminths, and that also drives allergic inflammation. Its hallmark is the coordinated production of the cytokines IL-4, IL-5, IL-10 and IL-13 by a diverse set of cell types, including T-helper 2 (Th2) cells, eosinophils, basophils, mast cells, ILC2s and nuocytes. Because these cytokines shape antibody isotype switching, mucus secretion, eosinophil recruitment and tissue remodeling, the pathway sits at the intersection of host defense, allergy and regenerative medicine. Recent work has clarified that type 2 immunity is not a single linear cascade but a modular program with multiple initiation modes, ranging from epithelial alarmin release to direct recognition of helminth products by sentinel cells. Sentinels of the type 2 immune response, such as tuft cells and ILC2s, act as early sensors that translate environmental cues into cytokine output. This architecture explains why the same pathway can be protective in helminth infection yet pathogenic in asthma and atopic dermatitis. For researchers, GO:0042092 provides a controlled vocabulary to annotate genes, cell states and perturbations that converge on type 2 cytokine signaling. Understanding its molecular logic is essential for vaccine design, anti-helminth therapy and the development of biologics that selectively dampen or amplify type 2 inflammation.
type 2 immune response At A Glance
| GO ID | GO:0042092 |
|---|---|
| GO term | type 2 immune response |
| Ontology | biological_process |
| Synonym | Th2 immune response; T-helper 2 type immune response |
| Major function | Resistance to extracellular organisms such as helminths and mediation of allergic pathology through IL-4, IL-5, IL-10 and IL-13 |
| Key cell types | Th2 cells, eosinophils, basophils, mast cells, nuocytes and ILC2s |
| Key cytokines | IL-4, IL-5, IL-10, IL-13, plus alarmins IL-25, IL-33 and TSLP |
| Downstream effects | IgE and IgG1 class switching, mucus production, eosinophilia, smooth-muscle contraction and tissue repair |
| Initiation modes | Epithelial alarmin release, helminth product sensing and sentinel cell activation |
What Is GO:0042092?
In our own words, GO:0042092 describes the immune response that confers resistance to extracellular organisms such as helminths and that also underlies pathological conditions such as allergy. It is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10 and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.
Why Is type 2 immune response Important in Cell Biology?
GO:0042092 is important because it defines the mechanistic core of immunity to helminths and of allergic disease, two areas of major clinical burden. The pathway controls antibody isotype selection, mucosal barrier function and tissue repair, and its dysregulation is implicated in asthma, atopic dermatitis and food allergy. Because type 2 cytokines also influence vaccine responses and tissue regeneration, the term is a practical anchor for immunology, vaccinology and regenerative medicine research.
• Provides the conceptual framework for host defense against helminths, a major global health challenge.
• Explains the immunological basis of allergy, including IgE production and eosinophilic inflammation.
• Links innate sentinel cells such as tuft cells and ILC2s to adaptive Th2 responses.
• Connects type 2 cytokines to metabolic and tissue-repair programs.
• Informs vaccine design by defining factors that shape humoral responses.
• Supports regenerative medicine through ILC2-mediated tissue regeneration.
• Offers druggable nodes (IL-4, IL-5, IL-13, alarmins) for asthma and atopic disease.
• Enables CRISPR-based causal testing of candidate genes in immune and epithelial cells.
What Happens During type 2 immune response?
Initiation by sentinel cells and alarmins
In simple terms: Sentinel cells act like smoke detectors that release alarm signals when they sense worms or allergens.
Type 2 immunity can be initiated through multiple modes, including direct sensing of helminth-derived products and allergen-associated cues by epithelial and innate sentinel cells. Sentinels of the type 2 immune response, such as tuft cells, release alarmins including IL-25, IL-33 and TSLP that activate downstream effector populations. Early events triggering initiation involve epithelial recognition, innate cell activation and cytokine release that together set the type 2 tone.
Activation of ILC2s and Th2 cells
In simple terms: Alarm signals wake up innate and adaptive immune cells that then produce the core type 2 cytokines.
Group 2 innate lymphoid cells (ILC2s) respond rapidly to alarmins and produce IL-5 and IL-13, while Th2 cells provide antigen-specific production of IL-4, IL-5 and IL-13. Nuocytes and other innate populations contribute to early cytokine output, bridging innate sensing and adaptive Th2 differentiation. This step establishes the cytokine milieu that defines GO:0042092.
Effector cytokine actions and antibody class switching
In simple terms: The cytokines instruct B cells to make allergy-associated antibodies and drive effector cell recruitment.
IL-4 and IL-13 promote class switching to IgE and IgG1 and act on epithelial and smooth-muscle cells to induce mucus production and contractility. IL-5 drives eosinophil development and recruitment, while IL-10 modulates the inflammatory set point. Regulation of the humoral type 2 immune response against allergens and helminths is a central output of the pathway.
Metabolic and tissue-repair programs
In simple terms: Type 2 immunity also switches on repair and metabolic programs that help tissues recover.
Metabolic regulation of the type 2 immune response is coupled to tissue repair and regeneration, with cytokine signaling influencing cellular metabolism in effector cells. ILC2-mediated type 2 responses promote thymus regeneration, illustrating how the pathway supports tissue remodeling beyond host defense. These repair functions link GO:0042092 to regenerative biology.
Key Genes Involved in GO:0042092 type 2 immune response
The following genes and proteins are central to the initiation, amplification and effector output of the type 2 immune response (GO:0042092).
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL4 | Signature type 2 cytokine driving Th2 differentiation and IgE class switching | Core effector cytokine for allergy and helminth immunity models |
| IL5 | Promotes eosinophil development, recruitment and survival | Target for eosinophilic asthma and hypereosinophilic syndromes |
| IL13 | Induces mucus production, goblet cell hyperplasia and airway remodeling | Central mediator of allergic airway disease |
| IL10 | Immunoregulatory cytokine that modulates type 2 inflammation | Studied for immune tolerance and helminth-driven regulation |
| IL25 | Epithelial alarmin that activates ILC2s | Initiation node for innate type 2 responses |
| IL33 | Alarmin released by epithelial and stromal cells that activates ILC2s | Biomarker and target in asthma and atopic disease |
| TSLP | Epithelial alarmin that primes type 2 cytokine production | Target in atopic dermatitis and asthma biologics |
| GATA3 | Master transcription factor for Th2 differentiation | Key regulator for CRISPR knockout studies of Th2 identity |
| RORA | Transcription factor supporting ILC2 function | Studied in innate lymphoid cell biology |
| IL4R | Receptor for IL-4 and IL-13 signaling | Target for dupilumab-type pathway inhibition studies |
| IL5RA | Receptor for IL-5 on eosinophils | Model for eosinophil depletion strategies |
| FCER1A | High-affinity IgE receptor subunit on mast cells and basophils | Relevant to mast cell and basophil activation assays |
| MS4A2 | Beta subunit of the high-affinity IgE receptor | Studied in mast cell signaling and allergy models |
| STAT6 | Transcription factor downstream of IL-4 and IL-13 signaling | Central node for point-mutation and knockout studies |
| JAK1 | Kinase mediating IL-4 and IL-13 receptor signaling | Target for JAK inhibitor research |
| JAK3 | Kinase involved in cytokine receptor signaling in lymphocytes | Relevant to immunodeficiency and allergy models |
| GATA3 | Th2 lineage specification and cytokine gene regulation | Used in reporter knock-in lines for Th2 tracking |
| RAG2 | Required for T and B cell receptor rearrangement underlying adaptive type 2 responses | Model for adaptive arm of type 2 immunity |
How Is type 2 immune response Regulated?
Type 2 immune responses are regulated at multiple levels. Initiation is controlled by sentinel cell alarmin release and by the modes of type 2 immune response initiation described in the literature. Cytokine signaling through IL-4R and STAT6 shapes the amplitude and duration of effector output. Metabolic regulation of the type 2 immune response further tunes effector cell function during tissue repair and regeneration. Humoral regulation against allergens and helminths involves coordinated class switching and antibody feedback. In addition, factors that influence the immune response to vaccination, including host and environmental variables, modulate the strength of type 2-associated humoral responses.
type 2 immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL4 | Allergic asthma and atopic dermatitis | Knockout and overexpression in T cell and epithelial lines |
| IL5 | Eosinophilic asthma | Knockout in eosinophil progenitors and reporter lines |
| IL13 | Airway remodeling and mucus hypersecretion | Point-mutation of receptor-binding residues and knock-in reporters |
| STAT6 | Type 2 signaling axis in allergy | Knockout and point-mutation to test phosphorylation sites |
| IL33 | Asthma and atopic disease | Overexpression and knockout in epithelial and stromal cells |
Allergy and asthma
Type 2 immune responses orchestrated by IL-4, IL-5 and IL-13 drive IgE production, eosinophilia, mucus hypersecretion and airway hyperreactivity, which are hallmarks of allergic asthma and atopic disease. Regulation of the humoral type 2 immune response against allergens is therefore a central therapeutic axis.
Helminth infection
GO:0042092 confers resistance to extracellular organisms such as helminths, and impaired type 2 immunity can lead to chronic infection. Sentinel cells and alarmins are critical for mounting effective anti-helminth responses.
Tissue repair and regeneration
Type 2 cytokines support metabolic and tissue-repair programs, and ILC2-mediated type 2 responses promote thymus regeneration, linking the pathway to regenerative medicine.
Vaccination and humoral immunity
Factors that influence the immune response to vaccination shape the magnitude and quality of antibody responses, including type 2-associated isotypes. Understanding these factors supports rational vaccine design.
From type 2 immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for Th2 cytokine production? | CRISPR knockout in primary T cells or Jurkat-derived lines |
| Does a specific phosphosite control type 2 signaling? | Point-mutation knock-in of the target residue |
| Where and when is a type 2 gene expressed? | Tagged knock-in reporter (e.g., fluorescent tag) |
| Does overexpression amplify type 2 output? | Overexpression cell model in epithelial or immune lines |
| Which genes shape ILC2-mediated regeneration? | Knockout and overexpression in ILC2 and tissue regeneration models |
| Can sentinel cell alarmin release be perturbed? | Knockout of alarmin genes in epithelial tuft cell models |
How to Study the type 2 immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome of type 2 effector cells | Defining Th2 and ILC2 gene signatures |
| Single-cell RNA-seq | Cell-type-specific expression in mixed immune populations | Mapping sentinel and effector cell states |
| ELISA / multiplex cytokine assays | IL-4, IL-5, IL-10, IL-13 protein levels | Quantifying type 2 cytokine output |
| Flow cytometry | Eosinophil, basophil and mast cell frequencies | Immunophenotyping allergic responses |
| CRISPR knockout screening | Gene requirement for type 2 cytokine production | Identifying novel regulators of GO:0042092 |
| Reporter knock-in imaging | Real-time expression of type 2 genes | Tracking ILC2 and Th2 activation |
| Metabolic flux assays | Glycolysis and oxidative phosphorylation | Linking metabolism to type 2 effector function |
| Tissue regeneration models | Regenerative capacity after type 2 perturbation | Testing ILC2-mediated repair |
Transcriptomic profiling of type 2 responses
RNA-seq and single-cell RNA-seq are used to define the gene expression programs of Th2 cells, ILC2s and sentinel cells during type 2 immune response initiation and effector phases. These methods identify cytokine and alarmin signatures that characterize GO:0042092.
Cytokine and antibody quantification
ELISA, multiplex assays and flow cytometry measure IL-4, IL-5, IL-10, IL-13 and IgE/IgG1 output, providing functional readouts of the humoral type 2 immune response against allergens and helminths.
Genetic perturbation with CRISPR
CRISPR knockout, point-mutation and knock-in approaches test causal roles of candidate genes in type 2 cytokine production and effector function. Reporter knock-ins enable tracking of Th2 and ILC2 populations.
Metabolic and tissue-repair assays
Seahorse metabolic assays and regeneration models assess how type 2 cytokines regulate cellular metabolism and tissue repair programs.
How CRISPR Can Be Used to Study GO:0042092 type 2 immune response
Knockout
CRISPR knockout of genes such as IL4, IL5, IL13, STAT6 or alarmin genes in primary T cells, ILC2s or epithelial lines can establish whether a candidate is required for type 2 immune response initiation or effector output. Knockout models are also used to test sentinel cell function in helminth and allergen settings.
Point Mutation
Point-mutation knock-in allows precise testing of phosphorylation sites, receptor-binding residues or catalytic residues in type 2 signaling components such as STAT6 and cytokine receptors. These models distinguish scaffolding from enzymatic functions within GO:0042092.
Knock-in
Tagged knock-in reporters for GATA3, IL13 or IL33 enable real-time tracking of Th2 and ILC2 activation in vitro and in vivo. Knock-in of epitope tags also supports proteomic and imaging studies of type 2 effector complexes.
Overexpression
Overexpression cell models for IL-4, IL-13, IL-33 or TSLP can amplify type 2 cytokine output and reveal sufficiency relationships in allergic and repair programs. These models are useful for testing downstream metabolic and tissue-repair effects.
How EDITGENE Supports type 2 immune response Research
Researchers studying type 2 immune response-related genes often need to determine whether a candidate gene is causally involved in cytokine production, sentinel cell activation or tissue repair. EDITGENE provides CRISPR-based cell model services that allow precise, reproducible perturbation of GO:0042092 components in relevant immune and epithelial backgrounds.
Contact EDITGENE today to design your custom CRISPR model for type 2 immune response research.
Frequently Asked Questions About type 2 immune response
What is GO:0042092 type 2 immune response?
GO:0042092 is the biological process of immunity against extracellular organisms such as helminths and the pathological basis of allergy, orchestrated by IL-4, IL-5, IL-10 and IL-13 from Th2 cells, eosinophils, basophils, mast cells and nuocytes.
What genes are involved in the type 2 immune response?
Key genes include IL4, IL5, IL13, IL10, IL25, IL33, TSLP, GATA3, STAT6, IL4R, IL5RA and FCER1A, among others.
What cells produce type 2 cytokines?
Th2 cells, ILC2s, eosinophils, basophils, mast cells and nuocytes are the principal producers of type 2 cytokines.
How is the type 2 immune response initiated?
It can be initiated by sentinel cells such as tuft cells that sense helminth or allergen cues and release alarmins including IL-25, IL-33 and TSLP.
What is the role of ILC2s in type 2 immunity?
ILC2s respond rapidly to alarmins, produce IL-5 and IL-13, and can promote tissue regeneration through type 2 responses.
How does type 2 immunity relate to allergy?
Type 2 cytokines drive IgE class switching, eosinophilia and mucus production, which underlie allergic asthma and atopic disease.
Can CRISPR be used to study type 2 immune response genes?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are widely used to test causal roles of type 2 genes in immune and epithelial cells.
What is the difference between type 1 and type 2 immune responses?
Type 2 immunity is defined by IL-4, IL-5, IL-10 and IL-13 and resistance to extracellular organisms, whereas type 1 immunity targets intracellular pathogens.
What diseases are linked to GO:0042092?
Allergic asthma, atopic dermatitis, food allergy and helminth infection are linked to type 2 immune responses.
How is the type 2 immune response regulated?
It is regulated by alarmin release, cytokine receptor signaling through STAT6, metabolic programs and factors influencing humoral responses to allergens and vaccines.
Conclusion
GO:0042092 type 2 immune response is a central biological process that coordinates defense against helminths and drives allergic pathology through IL-4, IL-5, IL-10 and IL-13. Its initiation by sentinel cells and alarmins, its effector outputs in antibody class switching and tissue repair, and its metabolic regulation make it a rich area for mechanistic and translational research. CRISPR-based cell models, combined with transcriptomic, cytokine and imaging readouts, provide a rigorous path to dissect the causal architecture of type 2 immunity. EDITGENE supports these efforts with knockout, point-mutation, knock-in, overexpression, library screening and bioinformatics services tailored to type 2 immune response targets.
References
- 1. Kopp EB et al.. 2023. Modes of type 2 immune response initiation.. Immunity 56(4):687-694 PMID: 37044059
- 2. Ding T et al.. 2022. Metabolic regulation of type 2 immune response during tissue repair and regeneration.. J Leukoc Biol 112(5):1013-1023 PMID: 35603496
- 3. Zimmermann P et al.. 2019. Factors That Influence the Immune Response to Vaccination.. Clin Microbiol Rev 32(2) PMID: 30867162
- 4. von Moltke J et al.. 2018. Sentinels of the Type 2 Immune Response.. Trends Immunol 39(2):99-111 PMID: 29122456
- 5. Haase P et al.. 2021. Regulation of the humoral type 2 immune response against allergens and helminths.. Eur J Immunol 51(2):273-279 PMID: 33305358
- 6. El-Naccache DW et al.. 2021. Early Events Triggering the Initiation of a Type 2 Immune Response.. Trends Immunol 42(2):151-164 PMID: 33386241
- 8. Nevo S et al.. 2024. Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response.. Sci Immunol 9(91):eabq6930 PMID: 38215193
